VBI Vaccines shares are trading higher after the company and Brii Biosciences announced the expansion of their hepatitis B partnership.
Portfolio Pulse from Bill Haddad
VBI Vaccines and Brii Biosciences have announced the expansion of their partnership on hepatitis B. This news has led to an increase in VBI Vaccines' share prices.
July 05, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
VBI Vaccines' shares are trading higher due to the expansion of their hepatitis B partnership with Brii Biosciences.
The expansion of the partnership with Brii Biosciences is a positive development for VBI Vaccines, as it could potentially lead to increased revenues and profitability. This news has been positively received by the market, leading to an increase in the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100